Ascendis Pharma AS Capital Reinvestment Ratio

Latest as of December 2025: 0.05x

Ascendis Pharma AS capital reinvestment ratio. Ascendis Pharma AS (ASND) has a Capital Reinvestment Ratio of 0.05x as of December 2025, meaning it reinvests 0% of its operating cash flow ($70.67 Million) in capital expenditures ($3.30 Million). Check Ascendis Pharma AS (ASND) reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.

Capital Reinvestment Ratio

0.05x
Capex / Operating Cash Flow

Operating Cash Flow

$70.67 Million
USD

Capital Expenditures

$3.30 Million
USD

Data as of

Dec 2025
Most recent filing

Capital Reinvestment Ratio of Ascendis Pharma AS (2013–2025)

Capital reinvestment ratio of Ascendis Pharma AS from 2013 to 2025. This chart tracks Ascendis Pharma AS's Capital Reinvestment Ratio across 2 annual periods. Also explore Ascendis Pharma AS equity growth rate to track the company's year-over-year net asset growth rate.

Ascendis Pharma AS Capital Reinvestment Ratio by Year (2013–2025)

Ascendis Pharma AS capital reinvestment ratio by year from 2013 to 2025. For the full cash flow conversion analysis, see ASND cash flow metrics.

Year Reinvestment Ratio Operating CF (USD) Capital Expenditures YoY Change
2025 0.16x $51.77 Million $8.15 Million ▼ -16.9%
2013 0.19x $6.31 Million $1.20 Million —
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow